NCT07294599

Brief Summary

To determine whether the time of day at which daily occlusion (patching) is administered - morning (08:00-10:00) versus evening (17:00-19:00) - affects the amount of visual-acuity improvement in the amblyopic eye in children with unilateral amblyopia. Rationale: While occlusion therapy remains the mainstay for treatment of childhood amblyopia, existing trials have focused on patching duration, not on the timing of occlusion. Diurnal or chronobiological factors - such as fluctuations in neuroplasticity, attention, compliance, or visual demand during the day - may influence the efficacy of patching. Understanding whether timing matters could help optimize occlusion therapy, improve outcomes, and reduce treatment burden.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started Dec 2025

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Dec 2025Jun 2026

First Submitted

Initial submission to the registry

December 8, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

December 14, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 19, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 14, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 14, 2026

Last Updated

December 26, 2025

Status Verified

December 1, 2025

Enrollment Period

6 months

First QC Date

December 8, 2025

Last Update Submit

December 18, 2025

Conditions

Keywords

Morning patchingEvening patchingAmblyopiaClinical trialAnisometriopiaStrabismus

Outcome Measures

Primary Outcomes (1)

  • Change in best-corrected visual acuity (BCVA) of the amblyopic eye

    Change in best-corrected visual acuity (BCVA) of the amblyopic eye from baseline to month 6, measured using a standardized logMAR (crowded) chart under full refractive correction, by a masked examiner.

    6 month

Secondary Outcomes (1)

  • stereoacuity

    6 month

Study Arms (2)

Morning patching

EXPERIMENTAL

Daily occlusion: 2 hours/day between 08:00-10:00. During patching: child performs near-vision activities (e.g. reading, puzzles, coloring). Duration: 6 months (unless withdrawal criteria met).

Behavioral: eye-patching

Evening patching

EXPERIMENTAL

Daily occlusion: 2 hours/day between 17:00-19:00. During patching: same near-vision tasks as Arm 1. Duration: 6 months (unless withdrawal criteria met).

Behavioral: eye-patching

Interventions

eye-patchingBEHAVIORAL

is a non-invasive treatment for Amblyopia ("lazy eye") in children. It involves covering (patching) the stronger, "good" eye so that the weaker (amblyopic) eye is forced to work. This encourages the brain to rely on the amblyopic eye, helping to strengthen its visual pathways.

Also known as: occlusion therapy
Evening patchingMorning patching

Eligibility Criteria

Age4 Years - 8 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age: 4-8 years.
  • Unilateral amblyopia.
  • Amblyopic-eye BCVA decimal 0.17-0.67 (≈ 6/36-6/9).
  • Fellow-eye BCVA ≥ 0.80 decimal (≈ 6/7.5 or better).
  • Amblyopia type: refractive-dominant or strabismic/mixed.
  • Parent/guardian consent obtained.

You may not qualify if:

  • Bilateral amblyopia.
  • Sensory-deprivation amblyopia (e.g., due to congenital cataract, ptosis, corneal opacity).
  • Ocular surgery within the past 6 months, or planned surgery during study.
  • Likely poor adherence (e.g., due to social, logistic, or family constraints).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

AmblyopiaStrabismus

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesVision DisordersSensation DisordersNeurologic ManifestationsEye DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsOcular Motility DisordersCranial Nerve Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessments (visual acuity, stereoacuity, ocular alignment) will be performed by trained examiners (e.g., optometrists/orthoptists) who are not involved in randomization, patching-instructions, or adherence monitoring, and who will remain masked to the child's assignment (morning vs evening patching). Allocation will be concealed via a central computer-generated randomization list; the enrolling investigator will not communicate assignment to the assessor. Standard operating procedures (chart, lighting, refractive correction, instructions) will be used uniformly. Data entered in the database will use non-descriptive group codes ("Group A" / "Group B"), and the statistician will remain blinded until the database is locked and primary analysis is complete.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Intervention model: Parallel-group, randomized assignment. Children with unilateral amblyopia will be randomized 1:1 to one of two arms: (1) morning patching (08:00-10:00 daily) or (2) evening patching (17:00-19:00 daily). Participants remain in their assigned arm for the full 6-month study and receive 2 hours/day occlusion with near-vision tasks. Outcomes (visual acuity ± stereoacuity) are assessed at baseline, 3 months (midpoint), and 6 months (final). Stratified randomization (by age group 4-\<6 vs 6-8 years, baseline VA severity, and amblyopia type) ensures balanced prognostic variables across arms. The purpose is efficacy comparison - to determine whether timing of daily occlusion (morning vs evening) affects improvement in the amblyopic eye after 6 months.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

December 8, 2025

First Posted

December 19, 2025

Study Start

December 14, 2025

Primary Completion (Estimated)

June 14, 2026

Study Completion (Estimated)

June 14, 2026

Last Updated

December 26, 2025

Record last verified: 2025-12